We planned to determine whether or not there is a difference in the level of muscle sympathetic nerve activity (MSNA) between hypertensive women and hypertensive men. Sympathetic activation of essential hypertension (EHT) has been associated with increased cardiovascular events, which are known to be less likely to occur in women than in men. Normal women have been reported to have less sympathetic nerve activity than men, but no reported data are available regarding gender differences in sympathetic activity in hypertensive subjects. We examined 36 patients with untreated and uncomplicated EHT comprising 18 women and 18 men, and 36 normal controls comprising 18 women and 18 men. MSNA was quantified as the mean frequency of single units and as multiunit bursts using the technique of microneurography. The hypertensive groups had greater sympathetic nerve activity than the control groups. Female hypertensives had lower (Po0.001) single unit hyperactivity (5671.7 impulses/100 cardiac beats) than male hypertensives (7271.7 impulses/100 cardiac beats). Normotensive females had lower (Po0.01) single unit activity (4273.6 impulses/100 cardiac beats) than normotensive males (5674.6 impulses/100 cardiac beats). Similar results were obtained for the frequency of multiunit burst activity. Hypertension in women is associated with a lower level of central sympathetic hyperactivity than in men. It is suggested that this may at least partly explain the observed lower hypertension-related cardiovascular events in women than in men. In addition, the findings may have implications for gender-specific management of hypertension.
Introduction
Sympathetic hyperactivity is known to occur in essential hypertension (EHT) and both have been implicated in its pathogenesis and ensuing cardiovascular risks. [1] [2] [3] [4] [5] [6] [7] [8] Follow-up studies of hypertensive populations have shown a greater incidence of cardiovascular events compared to normotensive populations, [9] [10] [11] with the cardiovascular events in hypertensive women being lower than in hypertensive men. [10] [11] [12] However, the reported investigations into the nature of hypertension in women have been less than those in men, 10, 13 and no reported data are available regarding the level of central sympathetic neural activation in hypertensive women compared to hypertensive men. Reports using microneurography to quantify directly the frequency of muscle sympathetic nerve activity (MSNA) in EHT relative to normotensive populations have examined a smaller number of women relative to men, with no gender comparisons. 4, 14 On the other hand, previously reported findings in normotensive populations have not been consistent as to whether MSNA levels are different between men and women. Young women may have a lower [15] [16] [17] [18] [19] or similar 20, 21 level of resting MSNA relative to young men. Also, older women may have a lower 15 or similar 17, 19 level of resting MSNA relative to older men.
We therefore planned, in untreated patients with uncomplicated EHT, to determine whether the mean frequency of MSNA in women (F-EHT) is different from that in men (M-EHT). For this purpose, MSNA was directly quantified by peroneal microneurography in two matched groups of women and men with untreated and uncomplicated EHT in comparison to two matched normal control groups of women (F-NC) and men (M-NC).
Materials and methods

Subjects
We prospectively examined 72 Caucasian subjects. They comprised 18 women (F-EHT) and 18 men (M-EHT) with untreated and uncomplicated EHT, and 18 normal women (F-NC) and 18 normal men (M-NC). All had similar sedentary occupational status and dietary habits, including a sodium intake of E400 mmol/day, and none was engaged in exercise training. In both groups of women, 15 were postmenopausal and none was on hormonal therapy. Patients were screened by history, physical and laboratory examination. None had evidence of secondary hypertension, left ventricular hypertrophy, peripheral vascular disease, arrhythmia, neuropathy or chronic disease that may influence the autonomic nervous system. Arterial blood pressure was defined on the basis of the average of at least three brachial sphygmomanometer readings, taken on separate occasions, using a standard measurement technique; the presence of hypertension was accepted with systolic arterial pressure X140 mm Hg or diastolic X90 mm Hg. 22, 23 Patients in the two hypertensive groups had established hypertension for no longer than 6 months and none were receiving drug therapy before the study. Subjects in the four groups were matched during recruitment according to gender, age, body weight, body mass index (BMI) and heart rate. In addition, subjects in each of the two hypertensive and the two control groups were matched for arterial blood pressure levels. Waist circumference was measured as the minimal circumference at the navel and used as a marker of abdominal fat. The investigation was carried out with the approval of St James's University Hospital Ethics Committee, and all subjects provided informed written consent.
General protocol
Microneurographic and haemodynamic measurements were obtained in an identical manner for all subjects during each session, as has previously been reported in detail. 6, 14 All investigations were performed under similar conditions between the hours of 0900 and 1200. Patients were asked to have had a light breakfast, and to empty their bladder before commencing the study. They were instructed to avoid nicotine and caffeine products for 12 h, as well as alcohol and strenuous exercise for 24 h before investigation. During each session, the subjects were studied in the semi-supine position when data attained a steady state for at least 30 min. Measurements were made in a darkened laboratory in which the temperature was constant between 22 and 241C. Resting arterial blood pressure was measured from the arm, using a mercury sphygmomanometer. Changes in heart rate and arterial blood pressure were monitored and recorded, using a standard electrocardiogram and a Finometer device (FMS, Arnhem, The Netherlands, TPD Biomedical Instruments).
Microneurography
Post-ganglionic MSNA was recorded from the right peroneal nerve, simultaneously with the other data as described previously. 6, 14 The neural signal was amplified ( Â 50 000) and it was either filtered (bandwidth of 700-2000 Hz) and integrated (time constant 0.1 s) for the purpose of generating bursts representing multiunit discharge, or left intact to examine raw action potentials. The output of action potentials and bursts from this assembly was passed to a PC-based data-acquisition system (LabView, National Instruments Corp., Austin, TX, USA), which digitized the acquired data at 12 000 samples/s (16 bits). MSNA was differentiated from skin sympathetic activity and afferent activity, as described previously.
6,14 Single units (s-MSNA) in the raw action potential neurogram were obtained by adjusting the electrode position, while using fast monitor sweep and on-line storage oscilloscope, to confirm the presence of consistent action potential morphology, as described previously. 6, 14, 24 Only vasoconstrictor units were accepted and examined, the criteria of acceptance being appropriate responses to spontaneous changes in arterial blood pressure during verification by a preliminary Valsalva manoeuver and isometric handgrip exercise. During the Valsalva manoeuvre, sympathetic activity increased during the latter part of phase-II and/or phase-III and decreased during phase-IV (corresponding to the decrease and increase of arterial blood pressure). During the isometric handgrip exercise, performed using a dynamometer (MIE Medical Research Ltd, Leeds, UK), a delayed increase of sympathetic nerve activity was observed. In addition, simultaneous measurement of calf vascular resistance confirmed the vasoconstrictor function of the observed neural activity.
Analysis was performed independently off-line, using dedicated software based on the LabView system (National Instruments Corp., Austin, TX, USA). This allowed raw action potential spikes to be scrutinized and electronically superimposed to establish the same morphology (s-MSNA). An electronic discriminator window was then used to objectively count the s-MSNA spikes with consistent morphology and a threshold discriminator was used to count the R-waves of the electrocardiogram. The mean frequency of s-MSNA was quantified over 1 min and over 100 cardiac beats, to avoid any interference by the length of the cardiac cycle. The bursts of MSNA were identified by inspection when the signal-to-noise ratio was greater than 3, and were counted and quantified in a similar manner to s-MSNA. The variability of repeated measurements of 2 min segments of recordings of s-MSNA units and MSNA bursts spanning a period of 30 min or those of two impalements performed within 60 min did not exceed 10%, in terms of twice the 95% confidence intervals around individual differences relative to the mean of the repeated measurements. 6 Statistics One-way analysis of variance (ANOVA) with Newman-Keuls post-tests was used to compare data between groups. The least square technique was used for assessing the linear relationship between variables. Values of Po0.05 were considered statistically significant. Data were presented as mean7 s.e.m.
Results
The details of the four groups are shown in Table 1 . They were matched in respect of age, body weight, BMI and heart rate. Also, the women and men of either the hypertensive or normal control groups were matched in respect of arterial blood pressure indices. The hypertensive groups had greater arterial blood pressure indices than the normal control groups. There were no significant differences in waist circumference between the four groups.
As expected, all indices of sympathetic nerve activity were greater in the hypertensive groups relative to their corresponding control (Table 1, Figure 1 ). Within the hypertensive groups, however, the indices of sympathetic nerve activity were significantly lower in women than in men. In addition, within the control normotensive groups, these indices were also significantly lower in women than in men. In both cases, sympathetic nerve activity of women was about one-fifth less than that of men (Figure 1) .
In each of the four groups, there was no significant correlation between sympathetic nerve activity and arterial blood pressure indices (at least r40.30, P40.05) or BMI (at least r40.05, P40.05). On the other hand, there was a significant correlation between sympathetic nerve activity and age (at least r40.50, Po0.02).
Discussion
Our study has shown for the first time in patients with EHT that the magnitude of MSNA hyperactivity in women was less than that in men. In subjects with normal arterial blood pressure levels, who were matched to the two groups with EHT, the level of MSNA in women was also lower than that in men. These findings indicate that the women's lower normal levels of this activity relative to men influenced the magnitude of their EHT-related sympathetic hyperactivity. As such, our findings are consistent with the proposals that sympathoexcitation is attenuated in women, and could provide one mechanism for the lower hypertension-related cardiovascular events in women than in men.
Although both women and men have been included in previous reports showing MSNA hyperactivity as a mechanism of EHT relative to normotensive subjects, 4, 6, [25] [26] [27] [28] [29] far fewer hypertensive women relative to hypertensive men were examined. In addition, there have been no reports of a direct comparison between men and women regarding the mechanism of sympathetic activation in EHT. In the present study, we matched equal numbers of women and men and avoided confounding factors that can interfere with sympathetic nerve activity. Thus, individual patients of the groups were Caucasians and were examined using the same protocol, under similar laboratory conditions, while avoiding the influence of age, dietary intake, body weight, large meal or visceral distension factors, which are known to affect sympathetic activity or its control. 14, 15, 17, 19, [30] [31] [32] [33] [34] We also quantified the mean frequency of s-MSNA units and that of MSNA multiunits. The former was considered as an index of the mean frequency of efferent sympathetic nerve 
Comparisons between Groups
Group data F-EHT (n ¼ 18) 
for hypertensive women (F-EHT) and men (M-EHT), normotensive control women (F-NC) and men (M-NC).
Comparisons were made using ANOVA post-tests (Newman-Keuls) and are shown in the right four columns. NS indicates insignificant difference (PX0.05).
Sympathetic drive and gender in hypertensives AJ Hogarth et al activity from the central nervous system to the leg, and the latter as an index that embraced units that might dynamically or reflexly change their frequency.
14 It is equally important to consider the limitations to our study. There were unavoidable differences in arterial blood pressure levels between the hypertensive and the control normotensive groups, and as such, we cannot entirely exclude an influence of baroreceptor reflex control of sympathetic nerve activity. However, greater arterial blood pressure levels in the EHT groups were associated with a greater rather than smaller sympathetic nerve activity than in the NC groups as has been commonly reported previously. [4] [5] [6] [7] [8] 14 Also, there were no significant differences in arterial blood pressure levels between women and men within the EHT or the NC groups, although as has previously been reported elsewhere, 6, 35, 36 we found no significant correlation between sympathetic nerve activity and arterial blood pressure level in individual subjects. Indeed, the differences in sympathetic nerve activity between women and men within the EHT or the NC groups were greater than the variability attending repeated measurements of this activity. 6 These considerations make it likely that the observed gender differences in sympathetic nerve activity were not solely attributable to differences in arterial blood pressure levels.
It is important to mention that our study quantified the central output of sympathetic nerve activity to the periphery, and as such this could differ from that destined to supply visceral organs. 8 However, in normal subjects a correlation has been reported between MSNA and the sympathetic drive to the heart and the kidney as assessed by norepinephrine spillover rate. 37, 38 Also, in EHT patients an increase of MSNA as well as the sympathetic drive to the heart and the kidney have been reported 8 indicating a generalized activation of the sympathetic drive. Indeed, there have been reports using indirect indices of sympathetic nerve activity showing that men have a predominance of sympathetic effects on the heart interval using spectral analysis, 39, 40 and higher circulating catecholamine levels than women. 41 These reported findings are consistent with our results of an existing difference in the sympathetic drive between women and men.
Our findings could have mechanistic and clinical implications, which are briefly considered here. Regarding the mechanistic implications, it has been proposed that several metabolic, hormonal and neural control mechanisms can affect sympathetic nerve activity. For instance, firstly, raised plasma insulin levels and insulin resistance have been related to sympathetic hyperactivity and could be associated with hypertension and obesity. 3, 8, 42, 43 However, the four groups of the present study were not obese and had similar BMI and waist circumference. Furthermore, the groups of women and men with hypertension had similar levels of arterial blood pressure. Secondly, leptin has been proposed to activate the sympathetic nervous system in animals, 44 although in humans, the levels of plasma leptin have been reported to be related to heart rate in men only and in general to obesity but not to sympathetic nerve activity. 45, 46 However, the four groups of the present study had similar BMI, waist circumference and heart rate. Thirdly, there are obvious differences in the plasma levels of sex hormones between women and men, and these have been tested in relation to MSNA. In one report examining normal women during the menstrual cycle, it was found that changes in plasma levels of oestrogen did not affect the level of MSNA. 47 In another report, increases of plasma levels of oestrogen and progesterone during the menstrual cycle were found to be associated with increased MSNA. 48 In that report, the baroreceptor reflex sensitivity controlling MSNA was found to be increased in relation to increased plasma levels of oestrogen and progesterone. 48 Although we did not examine the mechanisms underlying the observed gender-related differences, taking the above considerations together with previously published reports, 20, 41, 49, 50 it is reasonable to raise the possibility that the lower sympathetic activity in women could be related to their greater sympatho-inhibitory baroreceptor reflexes than those in men. This normal genderrelated difference would then affect the level of the central sympathetic hyperactivity attained in women and men with hypertension.
Regarding clinical implications, our results make it possible to propose a mechanism that might explain the observed lower cardiovascular risk in hypertensive women than in hypertensive men. [10] [11] [12] For instance, the hypertension-related sympathetic hyperactivity has been associated with the occurrence of cardiovascular complications, 5, 7, 8 and the lower hypertension-related sympathetic hyperactivity in women compared to men in our study may constitute at least one mechanism to explain the relatively lower cardiovascular risks seen in hypertensive women. It has been recommended that there is a need for clinical outcomes trials designed to establish any gender differences in response to therapy for cardiovascular disease, including EHT. 51 Indeed, our findings and the previously reported association between the sympathetic activation of hypertension and its cardiovascular complications 5, 7, 8 make it possible to argue that the choice of anti-hypertensive agents could be influenced by gender when sympathetic activation is of relevance. Some of these agents have been reported to have no effect on sympathetic activity [52] [53] [54] [55] [56] or increase it, 52, 54 whereas others either curtail sympathetic activation 57 or block sympathetic effects. [54] [55] [56] In conclusion, hypertension in women was associated with a lower level of central sympathetic hyperactivity than in men. It is suggested that this may at least partly explain the observed lower hypertension-related cardiovascular events in women than in men. Finally, these findings may have important implications for a more genderspecific management of hypertension.
